4133 Stock Overview
Manufactures and sells various recombinant proteins and antibodies. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Abnova (Taiwan) Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$27.90 |
| 52 Week High | NT$38.00 |
| 52 Week Low | NT$27.70 |
| Beta | 0.42 |
| 1 Month Change | -3.63% |
| 3 Month Change | -8.22% |
| 1 Year Change | -23.56% |
| 3 Year Change | -32.28% |
| 5 Year Change | 8.77% |
| Change since IPO | -47.08% |
Recent News & Updates
Shareholder Returns
| 4133 | TW Life Sciences | TW Market | |
|---|---|---|---|
| 7D | -2.6% | -2.2% | 0.9% |
| 1Y | -23.6% | -24.2% | 28.9% |
Return vs Industry: 4133 matched the TW Life Sciences industry which returned -24.2% over the past year.
Return vs Market: 4133 underperformed the TW Market which returned 28.9% over the past year.
Price Volatility
| 4133 volatility | |
|---|---|
| 4133 Average Weekly Movement | 1.4% |
| Life Sciences Industry Average Movement | 4.2% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in TW Market | 7.8% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 4133 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4133's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | n/a | n/a | www.abnova.com |
Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies. The company’s products portfolio includes SARS-CoV/CoV-2 DNA, RNA, proteins/peptides, lysates/slides, Ab pairs/kits, Ab arrays, polyclinic antibody, beads/dyes, in situ hybridization products, systems, and automations. It also offers MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and circulating rare cell antibodies.
Abnova (Taiwan) Corporation Fundamentals Summary
| 4133 fundamental statistics | |
|---|---|
| Market cap | NT$1.70b |
| Earnings (TTM) | NT$58.90m |
| Revenue (TTM) | NT$361.19m |
28.7x
P/E Ratio4.7x
P/S RatioIs 4133 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4133 income statement (TTM) | |
|---|---|
| Revenue | NT$361.19m |
| Cost of Revenue | NT$191.14m |
| Gross Profit | NT$170.05m |
| Other Expenses | NT$111.14m |
| Earnings | NT$58.90m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.97 |
| Gross Margin | 47.08% |
| Net Profit Margin | 16.31% |
| Debt/Equity Ratio | 0.03% |
How did 4133 perform over the long term?
See historical performance and comparisonDividends
2.6%
Current Dividend Yield74%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 10:44 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Abnova (Taiwan) Corporation is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xinkai Yu | Masterlink Securities Corp. |